In the Pipeline

Amidst the looming threat of bioterrorism and antimicrobial resistance, Ashok Chopra and his team at the University of Texas Medical Branch at Galveston have developed 3 new possible vaccines against the plague. They reported their findings in a study published last fall in Nature’s online journal npj Vaccines.
Without antibiotic treatment, bubonic plague’s mortality rate is 40-70%, while pneumonic and septicemic plagues virtually always kill. Current vaccines are in short supply, and some cause severe side effects.
Chopra and his team aim to do parallel studies so they can have several vaccine candidates in the pipeline.
Source: Kaiser Health News

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top